Testing effectiveness (Phase 2)Study completedNCT02130193
What this trial is testing
Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations
Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 102